Besides, this study hinted the repurposing values of some proteins approved for other diseases, such as prekallikrein for hereditary angioedema [51] and IL-6 sRa for inflammatory diseases [52], in VTE treatment. The gene discussed is IL6; the disease is hereditary angioedema.